Table 2.
The detailed information of patients with PPNAD.
| Continent | Percentage | Patients (%) |
|---|---|---|
| Europe | French | 65 (30.95) |
| Belgium | 7 (3.33) | |
| Poland | 5 (2.38) | |
| Portugal | 3 (1.43) | |
| Greece | 2 (0.95) | |
| The United Kingdom | 2 (0.95) | |
| Germany | 1 (0.48) | |
| Serbia | 1 (0.48) | |
| Austria | 1 (0.48) | |
| Asia | China | 43 (20.48) |
| Japan | 6 (2.86) | |
| India | 4 (1.90) | |
| Thailand | 3 (1.43) | |
| Turkey | 3 (1.43) | |
| Korea | 2 (0.95) | |
| Iran | 2 (0.95) | |
| Israel | 1 (0.48) | |
| North America | Canada | 27 (12.86) |
| The United States | 20 (9.52) | |
| Oceania | Australia | 4 (1.90) |
| South America | Brazil | 4 (1.90) |
| Africa | * | 3 (1.43) |
| Ethiopia | 1 (0.48) | |
| Total | 23 | 210 (100) |
*People of African descent.